Caris Life Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Caris Life Sciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $0.08 | $-0.11 | 172.7 % |
| Q2 | 2021-08-03 | $2.04 | $1.78 | 14.6 % |
| Q1 | 2021-04-29 | $1.85 | $1.66 | 11.5 % |
| Q4 | 2021-02-16 | $1.76 | $1.13 | 55.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $216.83M | $173.69M | 24.8 % |
| Q2 | 2021-08-03 | $85.70M | $83.05M | 3.18 % |
| Q1 | 2021-04-29 | $80.80M | $82.68M | -2.27 % |
| Q4 | 2021-02-16 | $81.57M | $82.14M | -0.70 % |
Caris Life Sciences (CAI) is scheduled to report earnings on February 12, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
The Actual EPS was $0.08, which beat the estimate of $-0.11.
The Actual Revenue was $216.8M, which beat the estimate of $173.7M.
Browse earnings estimates, EPS, and revenue on all stocks.